A Phase II Study to Assess the Efficacy and Safety of a Single Inhaled Dose of Albuterol Sulfate Dry Powder Via the Trivair Deposition System Versus Albuterol Sulfate HFA pMDI in Patients With Intermittent or Persistent Mild Asthma.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Salbutamol (Primary) ; Salbutamol sulfate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Acerus Pharmaceuticals
- 09 Mar 2018 Planned End Date changed from 1 Jun 2011 to 1 Oct 2015.
- 09 Mar 2018 Planned primary completion date changed from 1 Jun 2011 to 1 Apr 2013.
- 09 Mar 2018 Planned initiation date changed from 1 Mar 2011 to 1 Nov 2012.